Nexus Medical Partners logo

Nexus Medical Partners

North America, Massachusetts, United States, Quincy

Description

The Nexus Group is a private equity firm managing several funds with offices in Massachusetts and South Carolina and affiliates in San

Investor Profile

Nexus Medical Partners has made 15 investments, with 0 in the past 12 months and 13% as lead.

Stage Focus

  • Series B (33%)
  • Series C (27%)
  • Series A (13%)
  • Private Equity (7%)
  • Convertible Note (7%)
  • Debt Financing (7%)
  • Series D (7%)

Country Focus

  • United States (93%)
  • Germany (7%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Medical
  • Health Care
  • Therapeutics
  • Hospital
  • Infrastructure
  • Mobile
  • Wireless
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Nexus Medical Partners frequently co-invest with?

Accuitive Medical Ventures
North America, Georgia, United States, Duluth
Co-Investments: 2
DeNovo Ventures
North America, California, United States, Saratoga
Co-Investments: 2
South Carolina Research Authority
North America, South Carolina, United States, Columbia
Co-Investments: 4
Charleston Angel Partners
North America, South Carolina, United States, Charleston
Co-Investments: 2
Sunbridge Partners
North America, Ohio, United States, Beachwood
Co-Investments: 3
SV
North America, California, United States, Santa Clara
Co-Investments: 2
Ampersand Capital Partners
North America, Massachusetts, United States, Wellesley
Co-Investments: 2
Meritus Ventures
North America, Kentucky, United States, London
Co-Investments: 3
Windspeed Ventures
North America, Massachusetts, United States, Lexington
Co-Investments: 3
Upstate Carolina Angel Network
North America, South Carolina, United States, Greenville
Co-Investments: 5

What are some of recent deals done by Nexus Medical Partners?

Zipit Wireless

Greenville, South Carolina, United States

Zipit Wireless, Inc. delivers cloud-based software and cellular services for Internet of Things products.

InfrastructureMobileWireless
Convertible NoteMay 15, 2012
Amount Raised: $2,600,000
MyoScience

Redwood City, California, United States

MyoScience develops and commercializes technology-driven dermatological products.

BiotechnologyPharmaceuticalTherapeutics
Series DMar 21, 2012
Amount Raised: $33,000,000
Sabal Medical

Scranton, South Carolina, United States

Sabal Medical's aim is to bring nurses and pharmacists together, empowering them.

Health CareHospitalPharmaceutical
Debt FinancingAug 30, 2010
Amount Raised: $500,000
Zipit Wireless

Greenville, South Carolina, United States

Zipit Wireless, Inc. delivers cloud-based software and cellular services for Internet of Things products.

InfrastructureMobileWireless
Series CJul 10, 2010
Amount Raised: $4,000,000
Zipit Wireless

Greenville, South Carolina, United States

Zipit Wireless, Inc. delivers cloud-based software and cellular services for Internet of Things products.

InfrastructureMobileWireless
Series CFeb 15, 2010
Amount Raised: $3,600,000
Sabal Medical

Scranton, South Carolina, United States

Sabal Medical's aim is to bring nurses and pharmacists together, empowering them.

Health CareHospitalPharmaceutical
Series BJul 14, 2008
MyoScience

Redwood City, California, United States

MyoScience develops and commercializes technology-driven dermatological products.

BiotechnologyPharmaceuticalTherapeutics
Series BJul 11, 2008
Amount Raised: $10,400,000
Selah Technologies

Pendleton, South Carolina, United States

materials manufacturing company

Advanced MaterialsBiotechnologyManufacturingNanotechnology
Series AMay 1, 2008
Amount Raised: $1,600,000
Kiora Pharmaceuticals

Salt Lake City, Utah, United States

Kiora Pharmaceuticals develops medicines to treat eye diseases using its non-invasive, iontophoretic drug-delivery system.

BiotechnologyMedicalPharmaceutical
Series CMar 12, 2008
Amount Raised: $15,000,000
Presidio Pharmaceuticals

San Francisco, California, United States

Presidio Pharmaceuticals discovers, develops and commercializes novel therapeutics for viral infections, including HCV and HIV.

BiotechnologyMedicalPharmaceutical
Series BAug 29, 2007
Amount Raised: $26,000,000